- US-listed companies
- Coeptis Therapeutics Holdings, Inc.
- Income statement
Coeptis Therapeutics Holdings, Inc. (ZSQR) Income statement
Market cap
$57.63M
P/E ratio
| 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Research & development | - | - | 20,887 | 7 | 2 |
| Operating expenses | - | - | 34 | 21 | 10 |
| Operating income | -68,430 | -681,319 | -34,195,964 | -21,491,125 | -10,054,488 |
| Income before tax | - | - | -37,574,217 | -21,266,537 | -10,877,412 |
| Net income | -67,226 | 15 | -37,574,217 | -21,266,537 | -10,877,412 |
| Earnings per share | - | 1.62 | - | - | -5.65 |
| Diluted EPS | - | 1.62 | - | - | -5.65 |
| EBITDA | - | - |